sellWeak cluster of 210b5-1 plan
Saurabh Saha sold $5,451 of CNTA
Chief Executive Officer at Centessa Pharmaceuticals plc. 299 shares at an average of $18.23, traded Nov 25, 2024, filed Nov 27, 2024.
Warning score
0Value
$5,451
299 shares
Holdings after
575,661
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$5k at market
- 0Share of holdings soldSold 0.1% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-24-000175, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | MOption exercise Ordinary Shares10b5-1 | +299 | $5.84 | $1,746 | 575,960 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -299 | $18.23 | $5,451 | 575,661 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -299 | $0.00 | $0 | 3,956,981 | Nov 27, 2024 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $210k 15,000 shares | -6% | |
| 6Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $163k 10,000 shares | -7% | |
| 49Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $918k 55,000 shares | -17% | |
| 5Weak | Centessa Pharmaceuticals plc | David M Chao Chief Administrative Officer | $120k 7,000 shares | -3% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $99k 6,000 shares | -5% | |
| 22Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $175k 11,494 shares | -8% | |
| 48Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $876k 55,000 shares | -14% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $97k 6,000 shares | -5% | |
| 24Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $589k 30,955 shares | -36% | |
| 25Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $109k 6,471 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.